An in silico drug treatment model to assess the robustness of regional age-based dosing regimens for artemisinin-based combination therapies

Eva Maria Staehli Hodel; Katherine Kay; Daniel Hayes; Anja Terlouw; Ian Hastings

首页> 外文期刊>Malaria Journal >An in silico drug treatment model to assess the robustness of regional age-based dosing regimens for artemisinin-based combination therapies

【24h】

An in silico drug treatment model to assess the robustness of regional age-based dosing regimens for artemisinin-based combination therapies

机译：一种计算机内药物治疗模型，用于评估基于青蒿素的联合治疗的区域性基于年龄的给药方案的稳健性

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Malaria Journal》 |2012年第s1期|共页
作者
Eva Maria Staehli Hodel; Katherine Kay; Daniel Hayes; Anja Terlouw; Ian Hastings;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类医学寄生虫学;
关键词

相似文献

外文文献
中文文献
专利

1. Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices. [J] . Yeung S, Pongtavornpinyo W, Hastings IM, The American Journal of Tropical Medicine and Hygiene . 2004,第2Suppla期

机译：抗疟药耐药性，基于青蒿素的联合治疗以及模型对阐明政策选择的贡献。
2. Pharmacokinetic Profile of Artemisinin Derivatives and Companion Drugs Used in Artemisinin-Based Combination Therapies for the Treatment of Plasmodium falciparum Malaria in Children. [J] . Shane A Pawluk, Kyle J Wilby, Mary H H Ensom Clinical pharmacokinetics . 2013,第3期

机译：青蒿素衍生物和伴侣药物在以青蒿素为基础的联合疗法中治疗儿童恶性疟原虫的药物动力学研究。
3. Pharmacokinetic Profile of Artemisinin Derivatives and Companion Drugs Used in Artemisinin-Based Combination Therapies for the Treatment of Plasmodium falciparum Malaria in Children. [J] . Shane A Pawluk, Kyle J Wilby, Mary H H Ensom Clinical pharmacokinetics . 2013,第3期

机译：青蒿素衍生物的药代动力学概况和伴有蒿属植物的组合疗法治疗儿童疟原虫疟疾治疗。
4. On the Ontological Modelling of Co-medication and Drug Interactions in Medical Cancer Therapy Regimens for a Clinical Decision Support System [C] . Christoph Beierle, Bettina Sader, Christian Eichhorn, IEEE International Symposium on Computer-Based Medical Systems . 2017

机译：临床决策支持系统中药物治疗方案中联合用药和药物相互作用的本体模型
5. Development of pharmacokinetic-directed dosing of docetaxel in combination with a tyrosine kinase inhibitor for optimization of cancer drug therapy [D] . Pierce, Erica Lynn Bradshaw 2007

机译：与多西他赛结合酪氨酸激酶抑制剂的药代动力学指导剂量的开发，以优化癌症药物治疗
6. An in silico drug treatment model to assess the robustness of regional age-based dosing regimens for artemisinin-based combination therapies [O] . Eva Maria Staehli Hodel, Katherine Kay, Daniel Hayes, 2012

机译：一个计算机内药物治疗模型用于评估基于青蒿素的联合治疗的区域性基于年龄的给药方案的稳健性
7. An in silico drug treatment model to assess the robustness of regional age-based dosing regimens for artemisinin-based combination therapies [O] . Staehli Hodel Eva, Kay Katherine, Hayes Daniel, 2012

机译：一种 in silico 药物治疗模型，用于评估基于青蒿素的联合治疗的区域性基于年龄的给药方案的稳健性

An in silico drug treatment model to assess the robustness of regional age-based dosing regimens for artemisinin-based combination therapies

著录项

相似文献

相关主题

期刊订阅